Nature Of Operations

12 Months Ended

Dec. 31, 2011

Nature Of Operations [Abstract]

Nature Of Operations

1. Nature of Operations

Mylan Inc. and its subsidiaries (the "Company," "Mylan," "our" or "we") are engaged in the global development, licensing, manufacture, marketing and distribution of generic, brand and branded generic pharmaceutical products for resale by others and active pharmaceutical ingredients ("API") through two segments, "Generics" and "Specialty." The principal markets for Generics are proprietary and ethical pharmaceutical wholesalers and distributors, group purchasing organizations, drug store chains, independent pharmacies, drug manufacturers, institutions, and public and governmental agencies primarily within the United States ("U.S.") and Canada (collectively, "North America"), Europe, the Middle East and Africa (collectively, "EMEA"), and Australia, Japan, India and New Zealand (collectively, "Asia Pacific"). Generics also focuses on developing API with non-infringing processes to partner with generic manufacturers in regulated markets such as the U.S. and the European Union ("EU") at market formation. The principal market for Specialty is pharmaceutical wholesalers and distributors, pharmacies and healthcare institutions primarily in the U.S.